http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020512309-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020512309-A |
| titleOfInvention | Treatment methods and devices for improving bioavailability of leukotriene receptor antagonists |
| abstract | Disclosed are administration methods and devices for improving the bioavailability of leukotriene receptor antagonists. The method and device include an oral surface pH oral film dosage form designed to deliver a leukotriene receptor antagonist such as montelukast to the stomach in an amorphous precipitate suspended in an aqueous medium. . Also disclosed are devices and methods for treating diseases such as neurodegenerative diseases or conditions associated with leukotriene-induced neuroinflammation. The device is a film unit dosage form with an alkaline surface pH film layer and a safe and effective amount of montelukast. The device is primarily configured to achieve enteral delivery of montelukast. The method involves enterally delivering a safe and effective amount of montelukast (capable of crossing the blood brain barrier) to a human or animal in need of treatment. [Selection diagram] Fig. 5 |
| priorityDate | 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 338.